ZYKLISCHES POLYPEPTID ZUR BEHANDLUNG VON PHA TYPE 1B
European patent · EP3349779 · In force
Register entry
- Publication number
- EP3349779
- Application number
- EP16766922
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Sep 14, 2016
- Published
- Jul 25, 2018
- Granted
- Apr 29, 2020
- Protection ends at the latest
- Sep 13, 2036
- Next annual fee due
- Sep 30, 2027
- IPC classes
- A61K 38/12 (2006.01)C07K 7/56 (2006.01)C07K 7/60 (2006.01)A61P 5/40 (2006.01)
- Priority
- EP 15185093 14.09.2015
- PCT application
- PCT/EP2016/071636 14.09.2016
- PCT publication
- WO2017/046124 23.03.2017
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Oct 1, 2026
Next annual fee due on
- Next annual fee due on
- 30.09.2026 → 30.09.2027
Published in Swissreg on 01.10.2026
- Oct 1, 2025
Next annual fee due on
- Next annual fee due on
- 30.09.2025 → 30.09.2026
Published in Swissreg on 01.10.2025
- Oct 3, 2024
Change
Published in Swissreg on 03.10.2024
- Oct 1, 2023
Change
Published in Swissreg on 01.10.2023
- Oct 1, 2022
Change
Published in Swissreg on 01.10.2022
- May 14, 2020
Agent entered
- Representative
- Schmauder & Partner AG, Patent- und Markenanwälte VSP, Zwängiweg 7, 8038 Zürich
Published in Swissreg on 14.05.2020
- Apr 29, 2020
Granted
Published in Swissreg on 29.04.2020
Parties
Agent
Inventor
1180 Wien, AT
1160 Wien, AT
1220 Wien, AT
3003 Gablitz, AT
1100 Wien, AT
Martinez, Georgia 30907, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.